Uranium Royalty Corp. (NASDAQ:UROY – Get Free Report)’s share price traded up 6.8% during trading on Tuesday. The company traded as high as $4.34 and last traded at $4.3450. Approximately 918,142 shares changed hands during mid-day trading, a decline of 69% from the average session volume of 2,964,634 shares. The stock had previously closed at $4.07.
Analysts Set New Price Targets
A number of equities analysts have issued reports on the company. HC Wainwright restated a “buy” rating and set a $4.50 price target on shares of Uranium Royalty in a report on Thursday, July 16th. Weiss Ratings cut shares of Uranium Royalty from a “hold (c+)” rating to a “hold (c)” rating in a report on Monday, August 17th. National Bank Financial initiated coverage on shares of Uranium Royalty in a report on Wednesday, July 29th. They set an “outperform” rating and a $3.75 price objective on the stock. Finally, Zacks Research cut shares of Uranium Royalty from a “strong-buy” rating to a “hold” rating in a research report on Monday, September 14th. Three equities research analysts have rated the stock with a Buy rating and two have issued a Hold rating to the stock. According to data from MarketBeat.com, Uranium Royalty presently has an average rating of “Moderate Buy” and an average price target of $4.12.
Check Out Our Latest Research Report on UROY
Uranium Royalty Price Performance
Uranium Royalty (NASDAQ:UROY – Get Free Report) last posted its quarterly earnings data on Monday, September 14th. The company reported $0.10 earnings per share for the quarter, topping the consensus estimate of $0.05 by $0.05. Uranium Royalty had a return on equity of 10.86% and a net margin of 25.88%.The business had revenue of $51.68 million for the quarter, compared to analysts’ expectations of $52.23 million. Research analysts expect that Uranium Royalty Corp. will post 0.05 earnings per share for the current fiscal year.
Institutional Trading of Uranium Royalty
A number of institutional investors have recently modified their holdings of the business. CenterBook Partners LP increased its position in shares of Uranium Royalty by 828.7% during the fourth quarter. CenterBook Partners LP now owns 4,447,408 shares of the company’s stock valued at $15,744,000 after buying an additional 3,968,521 shares during the period. Banque Cantonale Vaudoise grew its stake in shares of Uranium Royalty by 9.7% in the first quarter. Banque Cantonale Vaudoise now owns 272,026 shares of the company’s stock worth $994,000 after purchasing an additional 24,000 shares during the last quarter. Renaissance Technologies LLC increased its position in Uranium Royalty by 206.5% during the 1st quarter. Renaissance Technologies LLC now owns 196,751 shares of the company’s stock valued at $718,000 after purchasing an additional 132,551 shares during the period. Quantbot Technologies LP bought a new position in shares of Uranium Royalty in the 2nd quarter worth approximately $421,000. Finally, The Manufacturers Life Insurance Company grew its position in shares of Uranium Royalty by 189.0% in the 1st quarter. The Manufacturers Life Insurance Company now owns 149,821 shares of the company’s stock worth $547,000 after buying an additional 97,977 shares during the period. 24.19% of the stock is currently owned by hedge funds and other institutional investors.
Uranium Royalty Company Profile
Uranium Royalty Corp. (NASDAQ: UROY) is a uranium-focused royalty and streaming company. It seeks exposure to the uranium sector through a portfolio of royalties, streams, debt and equity investments in uranium projects, as well as holdings of physical uranium. The company does not primarily operate mines; instead, its business model is designed to provide participation in uranium production and prices without directly bearing the full costs of mine development and operation.
Its interests are tied to uranium projects and properties in established producing and prospective regions, including Canada, the United States and Australia.
Recommended Stories
- Five stocks we like better than Uranium Royalty
- InvenTrust’s Sell-Off Opens a Potential Entry Point
- Curaleaf’s Higher Aurora Bid Raises the Stakes in Cannabis Consolidation
- Why onsemi’s Synaptics Pivot Could Be a Game Changer
- AI Chip Demand Gives Linde a New Growth Catalyst
Receive News & Ratings for Uranium Royalty Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Uranium Royalty and related companies with MarketBeat.com's FREE daily email newsletter.
